Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-25 · accession 0000097745-26-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-27 | 2026-02-25 | TMO | Shropshire Thomas B Jr. | SVP, GC | A - Grant | $0.00 | +978 | 6,058 | +19% | $0 |
| D | 2026-02-27 | 2026-02-25 | TMO | Shropshire Thomas B Jr. | SVP, GC | A - Grant | $0.00 | +4,281 | 4,281 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-25 | A | A | 978 | $0.00 | 6,057.52 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-25 | A | A | 4,281 | $0.00 | 4,281 | D | $513.68 · — to 2036-02-25 | 4,281 Common Stock | (F1) The option vests in four equal annual installments beginning on February 28, 2027. |